nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Animal Models of Negative Symptoms
|
Corbett, Roy |
|
1999 |
21 |
6S2 |
p. S211-S218 8 p. |
artikel |
2 |
Cognition in Schizophrenia
|
Mohs, Richard C |
|
1999 |
21 |
6S2 |
p. S203-S210 8 p. |
artikel |
3 |
Limitations of Dopamine-D2 Antagonists and the Search for Novel Antipsychotic Strategies
|
Marder, Stephen R |
|
1999 |
21 |
6S2 |
p. S117-S121 5 p. |
artikel |
4 |
NMDA-Sensitive Glutamate Antagonism
|
Lahti, Adrienne C |
|
1999 |
21 |
6S2 |
p. S158-S169 12 p. |
artikel |
5 |
Pharmacological Manipulation of D1-Dopamine Receptor Function in Schizophrenia
|
Sedvall, Göran C |
|
1999 |
21 |
6S2 |
p. S181-S188 8 p. |
artikel |
6 |
Serotonin–Glutamate Interactions
|
Aghajanian, George K |
|
1999 |
21 |
6S2 |
p. S122-S133 12 p. |
artikel |
7 |
The Cholinergic System in Schizophrenia Reconsidered:
|
Tandon, Rajiv |
|
1999 |
21 |
6S2 |
p. S189-S202 14 p. |
artikel |
8 |
The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia
|
Geyer, Mark A |
|
1999 |
21 |
6S2 |
p. S134-S142 9 p. |
artikel |
9 |
Therapeutic Implications of the Hyperglutamatergic Effects of NMDA Antagonists
|
Krystal, John H |
|
1999 |
21 |
6S2 |
p. S143-S157 15 p. |
artikel |
10 |
The Relevance of the Dopamine-D1 Receptor in the Cognitive Symptoms of Schizophrenia
|
Goldman-Rakic, Patricia S |
|
1999 |
21 |
6S2 |
p. S170-S180 11 p. |
artikel |